These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1210 related articles for article (PubMed ID: 33137809)

  • 21. Estimation of US SARS-CoV-2 Infections, Symptomatic Infections, Hospitalizations, and Deaths Using Seroprevalence Surveys.
    Angulo FJ; Finelli L; Swerdlow DL
    JAMA Netw Open; 2021 Jan; 4(1):e2033706. PubMed ID: 33399860
    [TBL] [Abstract][Full Text] [Related]  

  • 22. What does COVID-19 testing results really say? The real statistics concealed behind the accessible data.
    Rashki A; Hoseinpour Dehkordi A; Nemati R; Tavousi P
    J Med Virol; 2021 Oct; 93(10):5977-5987. PubMed ID: 34224155
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Characterization of coronavirus disease 2019 (COVID-19) in children and adolescents in Latin American and the Caribbean countries: A descriptive study].
    Atamari-Anahui N; Cruz-Nina ND; Condori-Huaraka M; Nuñez-Paucar H; Rondón-Abuhadba EA; Ordoñez-Linares ME; Pereira-Victoriod CJ
    Medwave; 2020 Sep; 20(8):e8025. PubMed ID: 32956342
    [TBL] [Abstract][Full Text] [Related]  

  • 24. COVID-19, Australia: Epidemiology Report 17 (Fortnightly reporting period ending 24 May 2020).
    COVID-19 National Incident Room Surveillance Team
    Commun Dis Intell (2018); 2020 Jun; 44():. PubMed ID: 32517645
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessing the age specificity of infection fatality rates for COVID-19: systematic review, meta-analysis, and public policy implications.
    Levin AT; Hanage WP; Owusu-Boaitey N; Cochran KB; Walsh SP; Meyerowitz-Katz G
    Eur J Epidemiol; 2020 Dec; 35(12):1123-1138. PubMed ID: 33289900
    [TBL] [Abstract][Full Text] [Related]  

  • 26. National age and coresidence patterns shape COVID-19 vulnerability.
    Esteve A; Permanyer I; Boertien D; Vaupel JW
    Proc Natl Acad Sci U S A; 2020 Jul; 117(28):16118-16120. PubMed ID: 32576696
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel ELISA Protocol Links Pre-Existing SARS-CoV-2 Reactive Antibodies With Endemic Coronavirus Immunity and Age and Reveals Improved Serologic Identification of Acute COVID-19
    Yuen RR; Steiner D; Pihl RMF; Chavez E; Olson A; Smith EL; Baird LA; Korkmaz F; Urick P; Sagar M; Berrigan JL; Gummuluru S; Corley RB; Quillen K; Belkina AC; Mostoslavsky G; Rifkin IR; Kataria Y; Cappione AJ; Gao W; Lin NH; Bhadelia N; Snyder-Cappione JE
    Front Immunol; 2021; 12():614676. PubMed ID: 33897682
    [TBL] [Abstract][Full Text] [Related]  

  • 28. COVID-19, Australia: Epidemiology Report 18 (Fortnightly reporting period ending 7 June 2020).
    COVID-19 National Incident Room Surveillance Team
    Commun Dis Intell (2018); 2020 Jun; 44():. PubMed ID: 32552623
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Impact of the COVID-19 epidemic in Friuli Venezia Giulia Region (Northern Italy): assessment of factors associated with the risk of death by competing risks analysis].
    Castriotta L; Rosolen V; Barbiero F; Tomietto M; de Dottori M; Barbone F; Zamaro G
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):128-135. PubMed ID: 33412803
    [TBL] [Abstract][Full Text] [Related]  

  • 30. COVID-19: Spatial analysis of hospital case-fatality rate in France.
    Souris M; Gonzalez JP
    PLoS One; 2020; 15(12):e0243606. PubMed ID: 33320895
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Variation in excess all-cause mortality by age, sex, and province during the first wave of the COVID-19 pandemic in Italy.
    Henry NJ; Elagali A; Nguyen M; Chipeta MG; Moore CE
    Sci Rep; 2022 Jan; 12(1):1077. PubMed ID: 35058508
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of SARS-CoV-2 Seropositivity During the First and Second Viral Waves in 2020 and 2021 Among Canadian Adults.
    Tang X; Sharma A; Pasic M; Brown P; Colwill K; Gelband H; Birnboim HC; Nagelkerke N; Bogoch II; Bansal A; Newcombe L; Slater J; Rodriguez PS; Huang G; Fu SH; Meh C; Wu DC; Kaul R; Langlois MA; Morawski E; Hollander A; Eliopoulos D; Aloi B; Lam T; Abe KT; Rathod B; Fazel-Zarandi M; Wang J; Iskilova M; Pasculescu A; Caldwell L; Barrios-Rodiles M; Mohammed-Ali Z; Vas N; Santhanam DR; Cho ER; Qu K; Jha S; Jha V; Suraweera W; Malhotra V; Mastali K; Wen R; Sinha S; Reid A; Gingras AC; Chakraborty P; Slutsky AS; Jha P;
    JAMA Netw Open; 2022 Feb; 5(2):e2146798. PubMed ID: 35171263
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A systematic review and meta-analysis of published research data on COVID-19 infection fatality rates.
    Meyerowitz-Katz G; Merone L
    Int J Infect Dis; 2020 Dec; 101():138-148. PubMed ID: 33007452
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SARS-CoV-2 Seroprevalence Structure of the Russian Population during the COVID-19 Pandemic.
    Popova AY; Smirnov VS; Andreeva EE; Babura EA; Balakhonov SV; Bashketova NS; Bugorkova SA; Bulanov MV; Valeullina NN; Vetrov VV; Goryaev DV; Detkovskaya TN; Ezhlova EB; Zaitseva NN; Istorik OA; Kovalchuk IV; Kozlovskikh DN; Kombarova SY; Kurganova OP; Lomovtsev AE; Lukicheva LA; Lyalina LV; Melnikova AA; Mikailova OM; Noskov AK; Noskova LN; Oglezneva EE; Osmolovskaya TP; Patyashina MA; Penkovskaya NA; Samoilova LV; Stepanova TF; Trotsenko OE; Totolian AA
    Viruses; 2021 Aug; 13(8):. PubMed ID: 34452512
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.
    Bajema KL; Wiegand RE; Cuffe K; Patel SV; Iachan R; Lim T; Lee A; Moyse D; Havers FP; Harding L; Fry AM; Hall AJ; Martin K; Biel M; Deng Y; Meyer WA; Mathur M; Kyle T; Gundlapalli AV; Thornburg NJ; Petersen LR; Edens C
    JAMA Intern Med; 2021 Apr; 181(4):450-460. PubMed ID: 33231628
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pseudo-likelihood based logistic regression for estimating COVID-19 infection and case fatality rates by gender, race, and age in California.
    Xiong D; Zhang L; Watson GL; Sundin P; Bufford T; Zoller JA; Shamshoian J; Suchard MA; Ramirez CM
    Epidemics; 2020 Dec; 33():100418. PubMed ID: 33221671
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of SARS-CoV-2 IgG antibodies in an area of northeastern Italy with a high incidence of COVID-19 cases: a population-based study.
    Stefanelli P; Bella A; Fedele G; Pancheri S; Leone P; Vacca P; Neri A; Carannante A; Fazio C; Benedetti E; Fiore S; Fabiani C; Simmaco M; Santino I; Zuccali MG; Bizzarri G; Magnoni R; Benetollo PP; Merler S; Brusaferro S; Rezza G; Ferro A
    Clin Microbiol Infect; 2021 Apr; 27(4):633.e1-633.e7. PubMed ID: 33253941
    [TBL] [Abstract][Full Text] [Related]  

  • 38. COVID-19, Australia: Epidemiology Report 16 (Reporting week to 23:59 AEST 17 May 2020).
    COVID-19 National Incident Room Surveillance Team
    Commun Dis Intell (2018); 2020 May; 44():. PubMed ID: 32522141
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Over- and under-estimation of COVID-19 deaths.
    Ioannidis JPA
    Eur J Epidemiol; 2021 Jun; 36(6):581-588. PubMed ID: 34322831
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sex differences in the incidence, mortality, and fatality of COVID-19 in Peru.
    Ramírez-Soto MC; Arroyo-Hernández H; Ortega-Cáceres G
    PLoS One; 2021; 16(6):e0253193. PubMed ID: 34125851
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 61.